Save up -80% on Brentuximab vedotin

Note: this is a drug discount program, not an insurance plan.

RX BIN: 015558
Group ID: DDN6600
Card Holder ID: DDN6600

Pharmacists and Patients support.

2018 Price of Brentuximab vedotin


* price without discount in nearest pharmacy. Price may vary.

Claim your free Brentuximab vedotin discount card

We offer free Brentuximab vedotin coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Brentuximab vedotin every time. What are you waiting for? Claim your prescription drug card now!

Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time

Brentuximab vedotin volume of distribution

The steady state volume of distribution is 6-10 L.

About RX24Drugs

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080

What is Brentuximab vedotin

Brentuximag vedotin or Adcetris is an antibody-drug conjugate that combines an anti-CD30 antibody and the drug monomethyl auristatin E (MMAE). It is an anti-neoplastic agent used in the treatment of Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Brentuximag vedotin was approved in 2011, and in January 2012, the drug label was revised to include a boxed warning of progressive multifocal leukoencephalopathy and death following JC virus infection.

Brentuximab vedotin mechanism of action

Brentuximab vedotin is composed of 3 parts: a chimeric human-murine IgG1 that targets CD30, monomethyl auristatin E (MMAE),which is a microtubule disrupting agent, and a protease-susceptible linker that covalently links the antibody and MMAE. The IgG1 antibody enables brentuximab vedotin to target tumor cells expressing CD30 on their cell surface then brentuximab vedotin gets internalized into the cell. Once inside, the linker is cleaved releasing MMAE which binds disrupts the microtuble network.

Dosage forms of Brentuximab vedotin

Injection, powder, lyophilized, for solutionintravenous50 mg/10.5mL
Powder for concentrate for solution for infusionIntravenous use50 mg
Powder for solutionintravenous50 mg
Prescription Generics


International Brands





Seattle Genetics, Inc.

CAS number






Affected organisms

Humans and other mammals

Indication of Brentuximab vedotin

Used in the treatment of Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Toxicity of Brentuximab vedotin

The most severe toxic reaction seen in patients is progressive multifocal leukoencephalopathy. Other toxicities include bone marrow suppression, infusion reactions, peripheral neuropathy, Stevens-Johnson syndrome, and tumor lysis syndrome.

RX24 Drugs Disclaimer: before buying a Brentuximab vedotin on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Brentuximab vedotin now!